Protein kinase signalling pathways involved in the up-regulation of the rat α1(I) collagen gene by transforming growth factor β 1 and bone morphogenetic protein 2 in osteoblastic cells
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Transforming growth factor β (TGFβ) family members are known for their important role in bone physiology. TGFβ " and, to a smaller extent, bone morphogenetic protein 2 (BMP-2) have been reported to regulate the gene expression of different osteoblast markers in itro. However, little is known about the molecular mechanisms involved in these actions. Here we report that BMP-2, like TGFβ " , up-regulated α1(I) collagen mRNA expression in ROS 17\2.8 osteoblastic cells. This was mediated through an increase in the transcriptional rate of the gene rather than through the stabilization of α1(I) collagen mRNA, and required new protein synthesis. In addition, TGFβ " -and BMP-2-induced increases in α1(I) collagen mRNA levels were both dependent on protein kinase C and protein tyrosine kinase activities. Furthermore, the mitogen-activated protein kinase (MAPK) [MAPK\extracellular signal-regulated protein kinase kinase 1\extracellular signal-regulated protein kinase
INTRODUCTION
Members of the transforming growth factor β (TGFβ) family, TGFβ and bone morphogenetic proteins (BMPs), have a major role in bone formation. Over the past decade, several studies have demonstrated TGFβ " and BMP-2 osteogenic properties in i o as well as their ability to modulate osteoblast cell proliferation and differentiation in itro [1] . In cellular models, TGFβ " has been reported to regulate the expression of specific genes such as osteocalcin, osteopontin, osteonectin, type I collagen, alkaline phosphatase [2] and the parathyroid hormone\ parathyroid-hormone-related peptide (' PTH\PTHrP ') receptor [3] . The effects of BMP-2 on osteoblastic cells have been less intensively investigated. However, BMP-2 has also been found to regulate the expression of alkaline phosphatase, the production of PTH-dependent cAMP and the synthesis of collagen [4] [5] [6] . Comparative studies have revealed that TGFβ " and BMP-2 can exert similar or opposite effects on osteoblast functions, depending on the studied cellular response and the cell line [5] . Although TGFβ " and BMP-2 are important factors for the regulation of the osteoblast phenotype, little is known about the molecular mechanisms involved in these actions.
TGFβ " and BMP-2 signal through their interaction with specific serine\threonine kinase cell surface receptors. For both factors, two classes of receptor (type I and type II) have been identified as signal-transducing receptors [7] . The type I and type II TGFβ " receptors form an oligomeric complex to bind their ligand co-operatively and transduce signals. BMP-2 type I and Abbreviations used : AP-1, activator protein 1 ; BMP, bone morphogenetic protein ; DRB, 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole ; ERK, extracellular signal-regulated protein kinase ; GAPDH, glyceraldehyde-3-phosphate dehydrogenase ; MAPK, mitogen-activated protein kinase ; MBP, myelin basic protein ; MEK, MAPK/ERK kinase ; PAI-1, plasminogen activator inhibitor 1 ; PKC, protein kinase C ; PTK, protein tyrosine kinase ; TGFβ, transforming growth factor β.
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(MEK-1\ERK)] pathway participated in the up-regulation of α1(I) collagen gene expression by TGFβ " and BMP-2. In response to either TGFβ " or BMP-2, the stimulation of α1(I) collagen mRNA levels was paralleled by an early increase in extracellular signal-regulated kinase protein activity. Moreover, the effects of both TGFβ " and BMP-2 on α1(I) collagen gene expression were markedly decreased in transfected ROS 17\2.8 cells expressing a dominant-negative MEK-1. Our findings therefore show that TGFβ " and BMP-2, which signal through discrete cell-surface receptors, are able to trigger analogous, if not identical, proteinphosphorylation-transducing cascades leading to comparable actions on the transcription of the α1(I) collagen gene in osteoblastic cells.
Key words : mitogen-activated protein kinase, mRNA expression, protein kinase C, ROS 17\2.8 cells.
type II receptors are also associated in a complex but the cooperativity of the two receptor species towards the binding of ligand is different from that of the type-I-type-II TGFβ " complex. Type I and type II receptors for TGFβ " have been characterized in osteoblastic cells [8] .
Other key components for the biological activities of TGFβ " and BMP-2 are signal transduction elements acting downstream of the serine\threonine kinase receptor. Findings in non-osteoblastic cells suggest that phospholipase C is involved in the effects of TGFβ " on cell proliferation [9] and gene expression [10] . Protein kinase C (PKC)-dependent activities have been also found to participate in TGFβ " -induced gene expression [10, 11] . In addition, components of the mitogen-activated protein kinase (MAPK) cascade have been shown to contribute to the regulation of gene transcription by TGFβ " in a variety of cell types [11] [12] [13] . Recently the SMAD family (for nomenclature see reference [13a] ) of signal transducers has been discovered and implicated in cell signalling by members of the TGFβ superfamily [14] . The intracellular components of TGFβ " and BMP-2 signalling in osteoblastic cells are as yet largely unknown. However, a novel member of the MAPK kinase kinase family, TGFβ-activated kinase 1 (' TAK1 '), has been found to activate the stress-activated protein kinase (' SAPK ') pathway in response to TGFβ in MC 3T3-E1 rat osteoblastic cells [15] .
In the present study we compared the effects of TGFβ " and BMP-2 on the gene expression of α1(I) collagen in the rat osteoblastic cell line ROS 17\2.8 and examined the transduction events, downstream of the receptor, involved in these actions. 
Cell culture
Rat osteosarcoma ROS 17\2.8 cells [16] were cultured at 37 mC in Dulbecco 's modified Eagle 's medium\F12 medium (Life Technologies) supplemented with 10 mM Hepes and 10 % (v\v) fetal bovine serum (WISENT, St. Bruno, Quebec, Canada), under air\CO # (19 : 1) in a humidified incubator. The cells were routinely subcultured every 3 days. For all experiments, cells were seeded at 1.5i10% cells\cm# in 60 mm culture plates in medium containing 5 % (v\v) fetal bovine serum, then grown for 48 h. After removal of the culture medium, the cell layer was rinsed once with serum-free medium and fed with fresh medium containing 2 % (v\v) fetal bovine serum, with or without the indicated reagent(s) or the corresponding vehicle. The viability of the ROS 17\2.8 cells in the presence of the different kinase inhibitors was assessed after 48 h (or 24 h) of incubation at the highest dose by the Trypan Blue exclusion method. Under these experimental conditions the percentage of viable cells was more than 94.6 % in all cases.
Northern blot analysis
Total RNA was isolated with the Trizol reagent in accordance with the protocol of the manufacturer (Life Technologies), fractionated on 1 % (w\v) agarose\formaldehyde gel (10 µg per lane) and transferred to a nylon membrane (Hybond Nj ; Amersham, Oakville, Ontario, Canada). Filters were prehybridized for 2 h at 65 mC in hybridization buffer [HB ; 0.3 M Na
, then hybridized overnight in the same buffer containing 10' c.p.m.\ml specific cDNA. Rat type I collagen (α1R1) cDNA [17] was a gift from Dr. D. Rowe. Filters were washed twice for 15 min in 2istandard saline citrate (SSC)\0.5 % SDS at 65 mC, then autoradiographed. As a control for loading, filters were probed in parallel with human glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA [18] . Signals were quantified by scanning densitometry and normalized against GAPDH mRNA values. Student 's t test was used to determine statistical significance.
Transcription assay in vitro
Nuclei were isolated and transcription was pursued in itro in the presence of [α-$#P]UTP by the method of Fei and Drake [19] . The radiolabelled transcripts were purified with the Trizol reagent (see above). α1R1 (I) collagen and GAPDH cDNA species (see above) were immobilized on a nylon membrane (see above). Filters prehybridized overnight at 65 mC in HB were hybridized for 72 h at 65 mC in the same buffer containing the radiolabelled transcripts. After being washed (twice for 15 min each in 2iSSC\0.5 % SDS at 65 mC), filters were subjected to autoradiography. Signals were quantified by scanning densitometry.
Immune complex kinase assay
The cells were washed twice in ice-cold PBS, scraped off plates in cell lysis buffer [20 mM Tris\HCl (pH 7.5)\150 mM NaCl\1 % (v\v) Nonidet P40\10 % (v\v) glycerol\1 mM PMSF\1 µg\ml leupeptin\1 µg\ml pepstatin\1 mM sodium orthovanadate\ 1 mM sodium metavanadate], then sonicated for 20 s. Lysates were cleared by centrifugation at 12000 g for 15 min and protein concentrations were determined with a bicinchoninic acid assay (Micro BCA ; Pierce, Rockford, IL, U.S.A.). Equal amounts of protein were rotated overnight with 1 µg of anti-ERK2 (C14 ; Santa Cruz Biotechnology, Santa Cruz, CA, U.S.A.). The anti-ERK2 antibodies cross-react with the ERK1 form. After binding to Protein A-Sepharose (Pharmacia Biotech, Uppsala, Sweden), the immune complexes were washed three times with cell lysis buffer and twice with kinase buffer [50 mM Tris\HCl (pH 
SDS\PAGE analysis of the samples was followed by autoradiography. The incorporation of $#P into MBP was analysed by scanning densitometry.
Cell transfections
A cDNA encoding the dominant-negative form of MEK-1 was created by the mutation of lysine-97 to alanine, as described previously [20] . This mutation was performed by PCR with wildtype MEK-1 cDNA as a template and the oligonucleotides 5h-GGCCAGAGCGCTAATTCATCTGG-3h as sense primer and 5h-CCAGATGAATTAGCGCTCTGGCC-3h as anti-sense primer (changes from the original sequence are underlined). The mutated cDNA (MEK-1 Ala-*( ) was then subcloned into BamHI and XhoI sites of the pCDNA3 mammalian expression vector (InVitrogen). The mutation was sequenced to ensure its correct composition. MEK-1 Ala-*( expression vector (pCMEK-1 Ala-*( ), or pCDNA3 empty vector (pC) as a control, was transfected into ROS 17\2.8 cells with the lipofectin reagent (Life Technologies). Stable clones were selected in culture medium containing 500 µg\ml G418. Resistant clones were then tested for the expression of MEK-1 Ala-*( or neomycin by Northern blotting. Two positive clones either expressing MEK-1 Ala-*( (pCMEK-1 Ala-*( -1 and pCMEK-1 Ala-*( -2) or containing the empty vector (pC-1 and pC-2) were used for further experiments.
RESULTS

Regulation of α1(I) collagen mRNA expression by TGFβ 1 and BMP-2
To compare the activities of TGFβ " and BMP-2 on gene expression in osteoblastic cells, we decided to examine whether Signalling in osteoblastic cells
Figure 1 Effects of TGFβ 1 and BMP-2 on α1(I) collagen (COL I) mRNA levels
Cells were treated for 24 or 48 h with increasing doses of TGFβ 1 (T) or BMP-2 (B). Total RNA was isolated at each time point and subjected to Northern blot analysis, as described in the Experimental section. A representative autoradiogram from four independent experiments is shown.
Figure 2 Effects of cycloheximide and actinomycin D on TGFβ 1 -and BMP2-induced increases in α1(I) collagen (COL I) mRNA levels
Cells were treated or not (control, C) with TGFβ 1 (T, 5 ng/ml) or BMP2 (B, 50 ng/ml) for 24 h, in the presence of vehicle (ethanol) or (A) cycloheximide (CX, 0.5 µg/ml) or (B) actinomycin D (AD, 3 ng/ml). Northern blot analysis was performed on total RNA, as described in the Experimental section. A representative autoradiogram from two independent experiments is shown.
or not BMP-2 could mimic the effect of TGFβ " on the expression of α1(I) collagen mRNA. TGFβ " has previously been described to increase the levels of α1(I) collagen mRNA in ROS 17\2.8 cells [2] . The cells were treated for 24 and 48 h with increasing doses of TGFβ " or BMP-2 ; the isolated total RNA was subjected to Northern blot analysis. As shown in Figure 1 , the steady-state level of α1(I) collagen mRNA was increased in a dose-and timedependent manner by both TGFβ " and BMP-2. For each of the two factors, the effect was detectable after 24 h of incubation and lasted for at least 48 h of treatment. In both cases no effect was observed before 24 h (results not shown). Interestingly, BMP-2 produced a greater increase in α1(I) collagen mRNA expression than did TGFβ " . Thus, after 48 h of incubation, the maximal dose of BMP-2 used (50 ng\ml) led to a maximal stimulation of 2.5p0.2-fold (P 0.001). In contrast, in the presence of TGFβ " , a maximal increase in α1(I) collagen mRNA levels of 1.5p0.1-fold (P 0.01) was observed with 5 ng\ml of TGFβ " , which was not augmented with a higher dose (10 ng\ml). In untreated cells an increase in the basal mRNA levels was observed from 24 to 48 h of incubation, indicating that in the absence of any exogenous treatment, the expression of α1(I) collagen mRNA increased with time in culture.
Effect of cycloheximide on TGFβ 1 -and BMP-2-induced increases in α1(I) collagen mRNA levels
The effects of TGFβ " and BMP-2 on α1(I) collagen mRNA expression were not detectable before 24 h, suggesting that the two factors might not act directly on α1(I) collagen gene promoter activity. To clarify this point we determined whether new protein synthesis was required in these mechanisms (Figure 2A) . After 24 h, in the presence of cycloheximide (0.5 µg\ml) neither TGFβ " (5 ng\ml) nor BMP-2 (50 ng\ml) was able to increase α1(I) collagen mRNA levels, indicating that protein synthesis de no o was critical for these cellular responses.
Effects of TGFβ 1 and BMP-2 on the transcription rate of the α1(I) collagen gene Up-regulation of mRNA levels could result from an increase in the gene transcription rate and\or in mRNA stability. We first analysed the effect of actinomycin D (a transcription inhibitor) on TGFβ " -and BMP-2-induced increases in α1(I) collagen mRNA levels ( Figure 2B ). Cells were treated for 24 h with TGFβ " (5 ng\ml) or BMP-2 (50 ng\ml) in the presence of vehicle (ethanol) or actinomycin D (3 ng\ml). Actinomycin D abolished the increase in α1(I) collagen mRNA levels induced by both TGFβ " and BMP-2, suggesting that a transcriptional event was part of the mechanism. To verify this hypothesis, a transcription assay was performed in itro with nuclei isolated from cells treated with either TGFβ " (5 ng\ml) or BMP-2 (50 ng\ml) for 48 h. Results from three independent experiments showed that TGFβ " and BMP-2 up-regulated the transcription rate of the α1(I) collagen gene by 2.5p0.7-fold and 3.9p0.9-fold respectively. Therefore these results confirmed that α1(I) collagen mRNA levels were transcriptionally controlled by TGFβ " and BMP-2. In addition, BMP-2 stimulated the transcription rate of the α1(I) collagen gene to a greater extent than did TGFβ " , corroborating the results obtained in Northern blot studies suggesting that BMP-2 had a stronger stimulatory effect than TGFβ " on α1(I) collagen gene expression.
Effects of TGFβ 1 and BMP-2 on α1(I) collagen mRNA stability
We next determined whether the two factors were also able to affect the stability of α1(I) collagen mRNA. Cells stimulated with TGFβ " and BMP-2 were, after a period of 24 h, incubated for up to 32 h in the presence of vehicle or DRB (12.5 µg\ml), an inhibitor of RNA polymerase II. As shown clearly in Figure 3 , neither TGFβ " nor BMP-2 altered the turnover of the mRNA.
Figure 3 Effects of TGFβ 1 and BMP-2 on the stability of α1(I) collagen (COL I) mRNA
Cells were treated either with TGFβ 1 (5 ng/ml) ( ) or BMP-2 (50 ng/ml) (=) or with no addition (#) for 24 h followed by the addition of DRB (12.5 µg/ml). Total RNA was isolated at the indicated time points and subjected to Northern blot analysis, as described in the Experimental section. Autoradiographic data were quantified by densitometry, normalized against 28 S rRNA values and expressed as a percentage of COL I mRNA present in cells before the addition of DRB. The figure summarizes the results from three independent experiments (meanspS.D.).
Involvement of protein kinase-dependent pathways in TGFβ 1 -and BMP-2-induced increases in α1(I) collagen mRNA expression
Because TGFβ " and BMP-2 both up-regulated α1(I) collagen mRNA expression in ROS 17\2.8 cells, it was of interest to examine whether these actions were mediated by comparable signal-transducing cascades. Protein kinases are involved in most of the cytokine signalling pathways. We therefore used several protein kinase inhibitors to assess the role of PKC and PTK activities in the up-regulation of α1(I) collagen mRNA expression by TGFβ " and BMP-2.
Effect of PKC inhibitors
Three different inhibitors of PKC were used : staurosporine, calphostin C and chelerythrine chloride. Each of these act on different domains of the PKC molecule (ATP-binding site [21] , regulatory domain [22] and catalytic domain [23] respectively) to inhibit the enzyme activity. Although staurosporine is a potent inhibitor of PKC, it also inhibits other kinases, including some tyrosine kinases [21] . In contrast, calphostin C and chelerythrine chloride are two highly specific inhibitors of PKC [22, 23] . The cells were treated with TGFβ " (5 ng\ml) or BMP-2 (50 ng\ml) in the presence of the different PKC inhibitors or vehicle (DMSO) for the indicated durations. Staurosporine (12.5 and 25 nM) markedly decreased the stimulatory effects of TGFβ " and BMP-2 on α1(I) collagen mRNA levels. Thus staurosporine (25 nM) inhibited the response to TGFβ " and BMP-2 respectively by approx. 67 % and 56 % (see Figure 4A) . Similarly, chelerythrine chloride (5 µM) inhibited the effects of TGFβ " and BMP-2 by approx. 46 % and 33 % respectively (see Figure 4B) , confirming that these cellular responses were mediated by PKCdependent activities. Agents such as chelerythrine chloride have previously been used in analogous studies under incubation conditions similar to ours to demonstrate the signalling role of PKC in other cellular models [24] . Nevertheless, to confirm the
Figure 4 Effects of PKC inhibitors on the TGFβ 1 -and BMP2-induced increases in α1(I) collagen (COL I) mRNA levels
Cells were treated or not (control, C) with TGFβ 1 (T, 5 ng/ml) or BMP2 (B, 50 ng/ml), in the presence of vehicle (DMSO) or (A) staurosporine (12.5 and 25 nM), (B) chelerythrine chloride (5 µM) or (C) calphostin C (400 nM) for 48 h (A, B) or 24 h (C). Northern blot analysis of isolated total RNA was performed, as described in the Experimental section. The autoradiograms shown are representative of those from at least three similar experiments.
involvement of PKC in our system, calphostin C (400 nM) was employed and was used in shorter incubations. This PKC inhibitor also strongly decreased the effects of TGFβ " and BMP-2 on α1(I) collagen gene expression, by approx. 86 % and 60 % respectively (see Figure 4C ).
Effect of tyrosine kinase inhibition
We also tested the participation of PTK in these signalling pathways ( Figure 5 ). The cells were treated as described above with increasing doses of genistein (a tyrosine kinase inhibitor) or vehicle. Genistein has previously been used in incubation conditions similar to ours to implicate PTK actions in other cell systems [24] . In the presence of genistein (15 µg\ml), TGFβ " and BMP-2 effects on α1(I) collagen mRNA expression were blocked,
Figure 5 Effect of genistein, a PTK inhibitor, on the TGFβ 1 -and BMP2-induced increases in α1(I) collagen (COL I) mRNA levels
Cells were treated or not with TGFβ 1 (5 ng/ml) or BMP2 (50 ng/ml) for 48 h, in the presence of increasing doses of genistein. Northern blot analysis of isolated total RNA was performed, as described in the Experimental section. A representative autoradiogram from three independent experiments is shown.
Figure 6 Effects of TGFβ 1 and BMP-2 on MAPK (ERK) activity in the absence or presence of genistein
Cultures were preincubated for 3 h in the presence of vehicle alone (DMSO) or vehicle plus genistein (30 µg/ml). Cells were then treated with serum alone (control, C), TGFβ 1 (T, 5 ng/ml) or BMP-2 (B, 50 ng/ml) for 30 min. Cell lysates were immunoprecipitated with anti-ERK antibodies and immunoprecipitates were subjected to kinase assay in vitro with MBP as substrate. Phosphorylated MBP was resolved by SDS/PAGE and detected by autoradiography. The autoradiograms shown are representative of two similar experiments.
indicating that genistein-sensitive PTK activities were involved in these transducing cascades.
No change in ROS 17\2.8 cell viability was observed after treatment with staurosporine, calphostin C, chelerythrine chloride or genistein (see the Experimental section).
Effects of TGFβ 1 and BMP-2 on MAPK (ERK) activity
PKC and PTK have been shown to participate in the protein phosphorylation cascades leading to the activation of MAPK family members [25] . In addition, the stimulation of ERK has been involved in TGFβ " -induced gene expression in other cell types. Consequently, we assessed whether TGFβ " -and BMP-2-induced increases in α1(I) collagen gene expression in ROS 17\2.8 cells could be correlated with a modification of MAPK (ERK) activity.
With the use of the same culture conditions as in previous experiments, cells were treated with TGFβ " (5 ng\ml) or BMP-2 (50 ng\ml) for 30 min (Figure 6 ) in the presence of either genistein (30 µg\ml) or vehicle (DMSO). ERK activity was determined by immune complex kinase assay with MBP as a substrate. An increase in ERK activity was observed at 30 min in response to TGFβ " and BMP-2 (approx. 2-fold and 3.5-fold respectively) compared with the control (serum alone). These effects on ERK activity were decreased by approx. 60k70 % in the presence of genistein. Genistein also had a slight inhibitory effect on the response in the presence of the serum alone. These observations indicated that TGFβ " and BMP-2 similarly modulated ERK activity under these experimental conditions. Therefore the up-regulation of α1(I) collagen gene expression by TGFβ " and BMP-2 was correlated with an early stimulatory effect on ERK activity ; genistein inhibited both of these effects.
When the same experiment was repeated with the PKC inhibitor chelerythrine chloride (10 µM) in place of genistein, chelerythrine chloride did not notably affect the TGFβ " -or BMP-2-induced increase of ERK activity, in contrast with the effect of genistein (results not shown).
Effects of MEK-1 Ala-97 expression on the regulation of the α1(I) collagen gene by TGFβ 1 and BMP-2
To examine further the role of the MAPK pathway in the regulation of α1(I) collagen gene expression by TGFβ " and BMP-2, the dominant-negative MEK-1 (MEK-1 Ala-*( )-expressing cell lines were established (see the Experimental section). As shown in Figure 7 (A), the stimulation of ERK activity by serum alone (control), TGFβ " (5 ng\ml) or BMP-2 (50 ng\ml) was markedly inhibited in cells expressing the mutant MEK-1 Ala-*( (pCMEK-1 Ala-*( -1) in comparison with cells transfected with the empty vector (pC-1) only. In parallel, TGFβ " and BMP-2 were no longer capable of increasing α1(I) collagen mRNA levels above control in pCMEK-1 Ala-*( -1 cells ( Figure 7B ). The same results were observed with the two other cell lines pCMEK-1 Ala-*( -2 and pC-2 (results not shown). These results indicate that the MEK-1\ERK cascade is important in the up-regulation of the expression of the α1(I) collagen gene by TGFβ " and BMP-2 in these cells.
DISCUSSION
Osteoblast differentiation is characterized by the production of bone organic matrix in which type I collagen is the main component. This extracellular matrix protein is important both for the structural integrity of the matrix and for its calcification (reviewed in [1] ). The capacity of TGFβ " to control the production and the remodelling of extracellular matrix in most tissues is well documented [26] . In ROS 17\2.8 osteoblast-like cells, TGFβ " has been shown to up-regulate the expression of genes such as those for osteonectin, osteopontin and type I collagen. Here we report that BMP-2, like TGFβ " , up-regulates the expression of the α1(I) collagen gene in this osteoblastic cell line. Furthermore, we demonstrate that the actions of TGFβ " and BMP-2 on the expression of this early marker of osteoblast differentiation are both mediated by transcriptional events. A number of investigations have shown that the effects of TGFβ " on gene expression can be exerted at the transcriptional level. Thus TGFβ " increases the promoter activity of plasminogen activator inhibitor 1 (PAI-1), α1(I) collagen and α2(I) collagen genes in fibroblasts [27, 28] . Our results confirmed the transcriptional action of TGFβ " on α1(I) collagen gene expression in osteoblastlike cells and indicated that BMP-2, too, stimulated α1(I) collagen mRNA expression by regulating the transcription rate of the gene. It seems likely that TGFβ " and BMP-2 did not exert a direct effect on the transcription of the α1(I) collagen gene in ROS 17\2.8 cells because their effect was not detectable before 24 h and required new protein synthesis. This is consistent with a requirement for the new synthesis of nuclear transcription factors. One of the important nuclear factors involved in the regulation of α1(I) collagen expression is the transcription factor activator protein 1 (AP-1) [29] . AP-1 has also been implicated in the effect of TGFβ " on the expression of several genes such as those for PAI-I [30] , collagenase [31] , osteocalcin [32] and α2(I) collagen [33] . Moreover, in osteoblast-like cells, the expression of AP-1 components such as c-Fos can be regulated by either TGFβ " [34] or BMPs (BMP-2\BMP-3) [35] . Further studies are now under way to determine the role of AP-1 transcription factors in the TGFβ " -and BMP-2-induced up-regulation of α1(I) collagen mRNA expression in ROS 17\2.8 osteoblastic cells.
An analysis of the signalling pathways involved in TGFβ " -and BMP-2-induced increases in α1(I) collagen mRNA levels showed that these actions were dependent at least in part on PKC activities. This was demonstrated by using three structurally unrelated PKC inhibitors (staurosporine, chelerythrine chloride and calphostin C) incubated under different conditions (for 24 or 48 h). PKC has a central role in several signal-transducing cascades [36] and has been linked to the up-regulation by TGFβ of other proteins such as PAI-1 and fibronectin in human lung carcinoma cells (A549) [9] . However, previous studies have reported that treatment with PMA leads to a down-regulation of the α1(I) collagen gene expression [37] in osteoblastic cells. However, these studies did not confirm whether, under the conditions of incubations used, PKC activity was up-regulated or down-regulated in response to the PMA added. Moreover, it is important to note that PKC consists of a large family of isoenzymes that are selectively activated depending on the agonist and the cell line [38] . Phorbol esters, in contrast, are less selective than natural agonists towards the different PKC isoforms. Additionally, depending on the cell line, PMA has variable effects on isoenzymes belonging to an atypical group such as PKCζ [39] . It has, for example, been reported that two distinct PKC isoforms (PKCδ and PKCε), induce opposite cell responses and different susceptibilities to PMA, even in the same cell line [40] . Therefore the PKC isoenzymes activated by the phorbol ester PMA might well be different from those activated by the natural agonist TGFβ " (or BMP-2) and therefore trigger different biological responses in cells. A detailed analysis of the activation of the specific PKC isoenzymes involved in each case will provide more insight into this apparent discrepancy.
PTK activities also participated in the signalling cascades involved in the up-regulation of α1(I) collagen mRNA expression by TGFβ " and BMP-2, as shown by the inhibitory effect of genistein on this cellular response. Thus the modulation of α1(I) collagen gene expression by TGFβ " and BMP-2 in ROS 17\2.8 cells was dependent, at least in part, on both PTK and PKC activities, which have been shown to lead to activation of the MAPK pathway [25] .
Recent studies have demonstrated the involvement of MAPK family members such as ERK and Jun kinase in the TGFβ signalling pathway [11] [12] [13] . MAPK family members are known for their role in the activation of targeted transcription factors that induce the expression of early genes such as c-fos [36] . Our work revealed that up-regulation of α1(I) collagen mRNA expression by TGFβ " and BMP-2 in ROS 17\2.8 osteoblast-like cells was correlated with an early increase in MAPK (ERK) activity. In contrast, when the action of TGFβ " and BMP-2 on Jun kinase activity was also examined, no significant effect was observed (results not shown). Additionally, the stimulation of ERK activity by TGFβ " and BMP-2 was markedly decreased in the presence of genistein, indicating that these actions were also at least partly mediated through upstream activation of PTK. These results support the hypothesis that MAPK (ERK) pathways could be involved in the TGFβ " and BMP-2 signalling leading to the up-regulation of α1(I) collagen mRNA in ROS 17\2.8 cells. This hypothesis was verified by using transfected ROS 17\2.8 cell lines expressing a dominant-negative MEK-1 (MEK-1 Ala-*( ) in which the effects of TGFβ " and BMP-2 on α1(I) collagen mRNA levels were noticeably decreased.
In summary, we have provided evidence demonstrating the participation of a pathway dependent on PKC, PTK and MEK-1\ERK in the up-regulation of α1(I) collagen gene expression by TGFβ " and BMP-2 in ROS 17\2.8 cells. Our findings show that in these cells, BMP-2 and TGFβ " , which signal through discrete cell-surface receptors, are able to trigger analogous, if not identical, transducing cascades leading to comparable actions on osteoblast-specific gene expression. No other transducing elements have been found to participate in the BMP-2 (or BMP-4) signalling pathway downstream of its receptor, except for the MAPK kinase kinase TGFβ-activated kinase 1 and the SMAD proteins. This study therefore demonstrates for the first time that PKC and PTK-dependent activities can participate in a BMP-2-stimulated cell response. We also show for the first time that BMP-2, like TGFβ " , is able to modulate MAPK (ERK) activity and that the MEK-1\ERK pathway participates in the regulation of α1(I) collagen gene expression by TGFβ " and BMP-2 in osteoblastic cells. Further identification of the intermediate kinases and regulatory proteins in these signal transduction pathways should lead us to a better understanding of the mechanisms involved in the regulation of gene expression in the osteoblast by TGFβ " and BMP-2.
